Item 1A. Risk Factors
3K characters. Original on sec.gov ·
Item 1A. Risk Factors
We face a variety of risks that are inherent in our business and our industry, including operational, legal, regulatory and product risks. Such risks could cause our actual results to differ materially from our forward-looking statements, expectations and historical trends. There have been no material changes from the risk factors disclosed in Part I, Item 1A “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025, except for those as updated in Part II, Item 1A "Risk Factors" in our Quarterly Report on Form 10-Q for the quarter ended June 30, 2026.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
The following table provides information as of September 30, 2026, with respect to shares of Common Stock repurchased by the Company during the quarter then ended:
| Fiscal Periods | Total number of shares purchased (thousands) | Average price paid per share | Total number of shares purchased as part of publicly announced plans or programs (thousands) | Approximate dollar value of shares that may yet be purchased under the plans or programs (millions) | ||||||||||||||||||||||
| 7/1/26-7/31/26 | — | $— | — | $4,389 | ||||||||||||||||||||||
| 8/1/26-8/31/26 | 1,892 | $149.22 | 1,892 | $4,107 | ||||||||||||||||||||||
| 9/1/26-9/30/26 | 1,833 | $142.18 | 1,833 | $3,846 | ||||||||||||||||||||||
| Total | 3,725 | $145.74 | 3,725 |
In June 2026, our Board of Directors authorized share repurchases of up to $4 billion (excluding applicable transaction fees and excise taxes) of our outstanding Common Stock through June 30, 2028. The new authorization took effect during the quarter ended September 30, 2026 upon the exhaustion of a prior authorization approved in May 2024. As of September 30, 2026, we have remaining capacity to repurchase up to $3.8 billion of Common Stock under the June 2026 authorization.
Previous: Item 4. Controls and Procedures · Next: Item 5. Other Information